MAMLD1 (CXorf6): A new gene involved in hypospadias

Hormone Research

Volumn 71, Issue 5, 2009, Pages 245-252

  Ogata, Tsutomu ^a   Laporte, Jocelyn ^b   Fukami, Maki ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

CXorf6; Hypospadias; MAMLD1; Testosterone

Indexed keywords

HAIRY ENHANCER OF SPLIT 3; MASTERMIND LIKE DOMAIN CONTAINING 1; MASTERMIND LIKE DOMAIN CONTAINING 2; MESSENGER RNA; NOTCH RECEPTOR; NUCLEIC ACID BINDING PROTEIN; REGULATOR PROTEIN; STEROIDOGENIC FACTOR 1; TESTOSTERONE; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5; UNCLASSIFIED DRUG;

CELL NUCLEUS INCLUSION BODY; DNA BINDING; FETUS CELL; FETUS DEVELOPMENT; GENE; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; HORMONE SYNTHESIS; HUMAN; HYPOSPADIAS; IN SITU HYBRIDIZATION; LEYDIG CELL; MAMLD1 GENE; MUTATIONAL ANALYSIS; NONHUMAN; NONSENSE MUTATION; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SERTOLI CELL; SEXUAL DEVELOPMENT; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR CELL; X CHROMOSOME;

ANIMALS; CHILD; CHILD, PRESCHOOL; CODON, NONSENSE; DNA-BINDING PROTEINS; HUMANS; HYPOSPADIAS; INFANT; INFANT, NEWBORN; MALE; MICE; NUCLEAR PROTEINS; PEDIGREE; RNA, MESSENGER; TESTOSTERONE; TRANSCRIPTION FACTORS;

EID: 63349085537     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000208797     Document Type: Short Survey

References (28)

1. Baskin LS, Ebbers MB: Hypospadias: anatomy, etiology, and technique. J Pediatr Surg 2007; 41:463-472.
2. Achermann JC, Hughes IA: Disorders of sex development; in Kronenberg HM, Melmed S, Polonsk KS, Larsen PR (eds): Williams Textbook of Endocrinology, ed 11. Philadelphia, Saunders, 2008, pp 783-848.
3. Beleza-Meireles A, Töhönen V, Söderhäll C, Schwentner C, Radmayr C, Kockum I, Nor-denskjöld A: Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias. Eur J Endocrinol 2008; 158: 729-739.
4. Beleza-Meireles A, Barbaro M, Wedell A, Töhönen V, Nordenskjöld A: Studies of a co-chaperone of the androgen receptor, FKBP52, as candidate for hypospadias. Reprod Biol Endocrinol 2007; 5: 8.
5. Beleza-Meireles A, Lundberg F, Lagerstedt K, Zhou X, Omrani D, Frisén L, Norden-skjöld A: FGFR2, FGF8, FGF10 and as candidate genes for hypospadias. Eur J Hum Genet 2007; 15:405-410.
6. Watanabe M, Yoshida R, Ueoka K, Aoki K, Sasagawa I, Hasegawa T, Sueoka K, Kamatani N, Yoshimura Y, Ogata T: Haplotype a nalysis of the estrogen receptor 1 gene in male genital and reproductive abnormalities. Hum Reprod 2007; 22: 1279-1284.
7. Beleza-Meireles A, Kockum I, Lundberg F, Söderhäll C, Nordenskjöld A: Risk factors for hypospadias in the estrogen receptor 2 gene. J Clin Endocrinol Metab 2007; 92: 3712-3718.
8. Fukami M, Wada Y, Miyabayashi K, Nishino I, Hase gawa T, Nordenskjöld A, Camerino G, Kretz C, Buj-Bello A, Laporte J, Yamada G, Morohashi K, Ogata T: CXorf6 is a causative gene for hypospadias. Nat Genet 2006; 38: 1369-1371.
9. Fukami M, Wada Y, Okada M, Kato F, Kat-sumata N, Baba T, Morohashi K, Laporte J, Kitagawa M, Ogata T: Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence. J Biol Chem 2008; 283: 5525-5532.
10. Bartsch O, Kress W, Wagner A, Seemanova E: The novel contiguous gene syndrome of myotubular myopathy (MTM1), male hypo- genitalism and deletion in Xq28: report of the first familial case. Cytogenet Cell Genet 1999; 85:310-314.
11. Biancalana V, Caron O, Gallati S, Baas F, Kress W, Novelli G, D'Apice MR, Lagier-Tourenne C, Buj-Bello A, Romero NB, Man-del JL: Characterisation of mutations in 77 patients with X-linked myotubular myopa-thy, including a family with a very mild phe-notype. Hum Genet 2003; 112:135-142.
12. Hu LJ, Laporte J, Kress W, Kioschis P, Sieben-haar R, Poustka A, Fardeau M, Metzenberg A, Janssen EA, Thomas N, Mandel JL, Dahl N: Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region. Hum Mol Genet 1996; 5: 139-143.
13. Laporte J, Guiraud-Chaumeil C, Vincent MC, Mandel JL, Tanner SM, Liechti-Gallati S, Wallgren-Pettersson C, Dahl N, Kress W, Bolhuis PA, Fardeau M, Samson F, Bertini E: Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. Hum Mol Genet 1997; 6:1505-1511.
14. Laporte J, Kioschis P, Hu LJ, Kretz C, Carls-son B, Poustka A, Mandel JL, Dahl N: Cloning and characterization of an alternatively spliced gene in proximal Xq28 deleted in two patients with intersexual genitalia and myo-tubular myopathy. Genomics 1997; 41:458-462.
15. Tsai TC, Horinouchi H, Noguchi S, Minami N, Murayama K, Hayashi YK, Nonaka I, Ishino I: Characterization of MTM1 mutations in 31 Japanese families with myotubu-lar myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypo-genita lism. Neuromuscul Disord 2005; 15: 245-252.
16. Kuzmiak HA, Maquat LE: Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 2006; 12: 306-316.
17. Morohashi K, Omura T: Ad4BP/SF-1, a transcription factor essential for the transcription of steroidogenic cytochrome P450 genes and for the establishment of the reproductive f unction. FASEB J 1996; 10: 1569-1577.
18. Ozisik G, Achermann JC, Jameson JL: The role of SF1 in adrenal and reproductive function: insight from naturally occurring muta- tions in humans. Mol Genet Metab 2002; 76:85-91.
19. Parker KL, Schimmer BP: Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev 1997; 18: 361-377.
20. Lin SE, Oyama T, Nagase T, Harigaya K, Kitagawa M: Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling. J Biol Chem 2002; 277:50612-50620.
21. Wu L, Sun T, Kobayashi K, Gao P, Griffin JD: Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 2002; 22: 7688 - 7700.
22. Artavanis-Tsakonas S, Rand MD, Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 1999; 284:770-776.
23. Iso T, Kedes L, Hamamori Y: HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003; 194:237-255.
24. Nam Y, Sliz P, Song L, Aster JC, Blacklow SC: Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 2006; 124:973-983.
25. Wilson JJ, Kovall RA: Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell 2006; 124:985-996.
26. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ: t(11; 19)(q21; p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 2003; 33: 208-213.
27. Androutsellis-Theotokis A, Leker RR, Sold-ner F, Hoeppner DJ, Ravin R, Poser SW, Rueger MA, Bae SK, Kittappa R, McKay RD: Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006; 442: 823-826.
28. Nishimura M, Isaka F, Ishibashi M, Tomita K, Tsuda H, Nakanishi S, Kageyama R: Structure, chromosomal locus, and promoter of mouse Hes2 gene, a homologue of Dro-sophila hairy and Enhancer of split. Genom-ics 1998; 49: 69-75.